Helpap Burkhard, Schmitz-Dräger Bernd J, Hamilton Peter W, Muzzonigro Giovanni, Galosi Andrea B, Kurth Karl H, Lubaroff David, Waters David J, Droller Michael J
Institute of Pathology, Hegau-Klinikum, 78207 Singen, Germany.
Virchows Arch. 2003 Apr;442(4):309-16. doi: 10.1007/s00428-002-0748-0. Epub 2003 Feb 11.
An international consultation on the diagnosis of non-invasive urothelial neoplasms was held in Ancona, Italy in May 2001. Besides histology and problems of classification, one group of experts (Committee no. 3) discussed the molecular pathology and cytometry of non-invasive urothelial carcinomas. In the following first part, special immunohistochemical and molecular markers for stratifications in bladder cancer were discussed including different cytokeratins (clone 34betaE12, CK 20), cell proliferation markers (Ki67/MIB-1, PCNA, AgNOR, DNA-cytometry), tumor suppressor genes and oncogenes (p53, p21, erb-B2, bcl-2), different receptor expressions of epidermal growth factor and vascular endothelial growth factor and others. These molecular markers were analyzed in diagnosis of urothelial carcinomas, recurrences, progression and response to treatment.
2001年5月,一场关于非侵袭性尿路上皮肿瘤诊断的国际研讨会在意大利安科纳举行。除了组织学和分类问题外,一组专家(第3委员会)讨论了非侵袭性尿路上皮癌的分子病理学和细胞计数法。在接下来的第一部分中,讨论了用于膀胱癌分层的特殊免疫组织化学和分子标志物,包括不同的细胞角蛋白(克隆34βE12、CK 20)、细胞增殖标志物(Ki67/MIB-1、PCNA、AgNOR、DNA细胞计数法)、肿瘤抑制基因和癌基因(p53、p21、erb-B2、bcl-2)、表皮生长因子和血管内皮生长因子的不同受体表达等。这些分子标志物在尿路上皮癌的诊断、复发、进展及治疗反应中进行了分析。